D
RTW Biotech Opportunities Ltd RTWFF
$1.64 $0.2820.59% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue 936.90% 936.90% 132.83% 132.83% 52.24%
Total Revenue 936.90% 936.90% 132.83% 132.83% 52.24%
Cost of Revenue -- -- -- -- --
Gross Profit 936.90% 936.90% 132.83% 132.83% 52.24%
SG&A Expenses 19.12% 19.12% 79.48% 79.48% 58.32%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 23.88% 23.88% 82.26% 82.26% 56.87%
Operating Income 972.22% 972.22% 2.19% 2.19% -62.22%
Income Before Tax -147.46% -147.46% -201.86% -201.86% 164.15%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -147.46% -147.46% -201.86% -201.86% 164.15%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -147.46% -147.46% -201.86% -201.86% 164.15%
EBIT 972.22% 972.22% 2.19% 2.19% -62.22%
EBITDA -- -- -- -- --
EPS Basic -148.28% -148.28% -163.87% -163.87% 67.06%
Normalized Basic EPS -77.59% -77.59% -30.18% -30.18% 966.67%
EPS Diluted -148.28% -148.28% -163.87% -163.87% 67.06%
Normalized Diluted EPS -77.59% -77.59% -30.18% -30.18% 966.67%
Average Basic Shares Outstanding -1.68% -1.68% 59.38% 59.38% 58.07%
Average Diluted Shares Outstanding -1.68% -1.68% 59.38% 59.38% 58.07%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --